Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 280

Results For "LA"

8960 News Found

Glenmark’s PMS study allays concerns on use of Favipiravir for Covid-19 treatment
News | September 15, 2021

Glenmark’s PMS study allays concerns on use of Favipiravir for Covid-19 treatment

These were the findings of the Post Marketing Surveillance (PMS), study of Favipiravir (FabiFlu) on over 1000 patients


Apollo Cancer Centres launch India’s first virtual duathlon
Hospitals | September 15, 2021

Apollo Cancer Centres launch India’s first virtual duathlon

Proceeds raised from the duathlon will go towards cancer treatment of children identified by the hospital


Lupin launch a generic version of pain reliever for osteoarthritis in the US
Drug Approval | September 15, 2021

Lupin launch a generic version of pain reliever for osteoarthritis in the US

Ibuprofen and Famotidine tablets (Duexise) had estimated annual sales of US $ 765 million in the US as if July 21


Serum Institute to supply polio vaccine for India’s universal immunisation plan
Drug Approval | September 15, 2021

Serum Institute to supply polio vaccine for India’s universal immunisation plan

The first lot of IPV will be supplied to the government this month as per the requirement of the Health Ministry


Laurus Labs, Unitaid and Clinton Health Access Initiative to develop HIV medication for children
Public Health | September 14, 2021

Laurus Labs, Unitaid and Clinton Health Access Initiative to develop HIV medication for children

Laurus will be incentivised for a portion of its development and commercialisation costs. CHAI will also provide technical and regulatory support to enable accelerated generic development


Medical institutes urge action on Front-of-Pack labels (FOPL) to address India’s health crisis
Public Health | September 14, 2021

Medical institutes urge action on Front-of-Pack labels (FOPL) to address India’s health crisis

Packaged junk food which is a major component of unhealthy diets is responsible for more deaths worldwide than any other risk factor


BDR Pharmaceuticals launch Cabozantinib to treat thyroid cancer
Drug Approval | September 14, 2021

BDR Pharmaceuticals launch Cabozantinib to treat thyroid cancer

In several trials like Celestial (double-blind phase III trial), Phase III Meteor trials, Cabozantinib has shown better PFS (Progression-Free Survival).


Prevest DenPro Limited's IPO to open on BSE SME platform on September 15
Clinical Trials | September 14, 2021

Prevest DenPro Limited's IPO to open on BSE SME platform on September 15

The net proceeds from the issue will be utilised towards the purchase of machinery, modernising existing units and expansion of its R&D facilities


ENTOD Pharma launches surgical division HyTek
Medical Device | September 14, 2021

ENTOD Pharma launches surgical division HyTek

The division will focus on products that are required during ophthalmic surgical procedures like cataracts and refractive surgeries among others


Boehringer Ingelheim and Twist Bioscience ink antibody discovery collaboration
News | September 13, 2021

Boehringer Ingelheim and Twist Bioscience ink antibody discovery collaboration

Research collaboration covers multiple antibody research programs